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Abstract (Word count: 254) 
 
Purpose: To examine premature mortality in a nationally representative cohort of primary care patients who have harmed 
themselves. 
Methods: During 2001-2013, 385 general practices in England contributed data to the Clinical Practice Research 
Datalink (CPRD) with linkage to Office for National Statistics (ONS) mortality records. We identified 30,017 persons aged 
15-64 years with a recorded self-harm episode. We estimated the relative risks of all-cause and cause-specific natural 
and unnatural mortality using a comparison cohort, matched on age, gender and general practice. 
Results: We found elevated risk of dying prematurely from any cause among the self-harm cohort, particularly during the 
first follow-up year: adjusted hazard ratio (HR) 3.6, 95% confidence interval (CI) 3.1-4.2. The elevation in suicide risk 
within a year was especially great: adjusted HR 54.4, CI 34.4-86.3. Beyond the first year, suicide risk declined sharply but 
remained much higher than in the comparison cohort. Large risk elevations throughout the follow-up period were also 
observed for accidental, alcohol-related and drug poisoning deaths. At 10 years of follow up, cumulative incidence values 
were 6.5% (CI 6.0-7.1) for all-cause mortality and 1.3% (CI 1.2-1.5) for suicide. 
Conclusions: Primary care patients who have harmed themselves are at greatly increased risk of dying prematurely by 
natural and unnatural causes, and especially so within a year of a first episode. These individuals consult at a relatively 
high frequency, which presents a clear opportunity for preventive action. Primary care patients with myriad co-morbidities, 
including self-harming behavior, mental disorder, addictions, and physical illnesses, will require concerted, multi-pronged, 
multidisciplinary collaborative care approaches. 
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Introduction 
 
Self-harm is a major public health problem. Deprived populations have higher incidence of self-harm,
1
 and national 
incidence rates have risen in the wake of the economic downturn and subsequent austerity era.
2
 Greatly reduced life 
expectancy and elevated risk of early death has been reported among people who present to hospital following self-harm 
in Australia,
3
 Canada,
4
 Denmark,
5
 England,
6
 Finland,
7
 New Zealand,
8
 Norway,
9
 Sweden,
10
 and Taiwan.
11
 However, very 
little is known about mortality risk among primary care patients who have harmed themselves. A better understanding of 
mortality risk in this population is required, because national clinical guidelines in England, issued by the National Institute 
for Health and Clinical Excellence (NICE), have emphasized the important role of general practitioners (GPs) and primary 
healthcare teams in managing and monitoring risk in these patients over both short-
12
 and long-term
13
 follow-up. We have 
previously examined clinical management after a recent self-harm episode in the same primary care patient cohort.
14
 We 
found an unexpectedly low rate of referral to mental health services, and suboptimal levels of adherence to a specific 
NICE recommendation against prescribing of tricyclic antidepressant medication following self-harm,
13 14
 illustrating the 
clinical importance of examining premature morality risk in this population.    
 
For the study reported in this paper we utilized electronic health data linked to national mortality records to investigate risk 
of dying prematurely after self-harm in a large primary care cohort in England. By examining mortality outcomes from both 
unnatural and natural causes, our intention was to highlight the potential clinical and public health benefits of addressing 
the physical health as well as the psychosocial needs of these patients. We currently know very little about long-term 
mortality risk among these individuals, because researchers have traditionally tended to examine risk in the immediate 
post-harm period.
4
  
 
Methods 
 
Data source 
The study was conducted using electronic health data extracted from the Clinical Practice Research Datalink (CPRD) 
obtained under licence from the UK Medicines and Healthcare products Regulatory Agency.
15
 The CPRD is one of the 
world’s largest population-based, longitudinal, primary care databases containing anonymised patient information 
provided by general practices participating in the CPRD. In the UK National Health Service (NHS) over 98% of the 
population is registered with a GP with practices providing healthcare free at the point the access. In December 2013, 
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data were available for 684 general practices and more than 13 million patients with distributions of age and gender 
comparable to those reported in the UK national population census.
15 16
 Validation studies on the CPRD have 
demonstrated that it contains consistent, high-quality data.
17
 Diagnoses are coded using the Read system that is in 
standard usage in UK general practice.
18 
An explanation of Read coding, and how diagnostic information is routinely 
recorded in the CPRD, is provided in Appendix 1. 
  
Self-harm definition 
We used the definition "any act of self-poisoning or self-injury, irrespective of the apparent purpose" from NICE clinical 
guideline number 16.
12
 Using this broad conceptualisation we developed a list of Read codes to delineate all self-harm 
cases across the spectrum from milder forms of non-suicidal behavior through to near-fatal suicide attempts. The Read 
code list is available online at: https://clinicalcodes.rss.mhs.man.ac.uk/
19
 ‘Self-harm’ is a commonly used term in the UK, 
referring to all episodes irrespective of purpose; cases of attempted suicide with clear intent to die represent a subset 
among all persons who have harmed themselves. Appendix 2 gives a detailed description of the psychiatric and co-
morbid physical illness diagnostic categories that we examined.
 
 
Self-harm cohort and matched comparison cohort 
The cohort consisted of a nationally representative sample of patients who were coded for an incident presentation of 
self-harm to primary care during 2001-2013 at ages 15-64 years. The rationale for imposing these age restrictions was 
that the determinants and implications of self-harm in children and older adults are quite distinct from those of the rest of 
the population, and therefore warrant separate consideration. Among older persons who harm themselves, specific 
mechanisms such as bereavement, loneliness and social isolation
20,21
 and physical illness, multi-morbidity and 
impairment
21
 play a greater role; children aged below 15 years who harm themselves may have less suicidal intent and a 
relatively low long-term risk of dying by suicide.
22
 Our intention was to preclude prevalent-cohort bias by delineating an 
incident cohort,
23,24
 and we therefore required patients to have been registered with a contributing practice for at least one 
full year prior to their index episode. Each ‘exposed’ self-harm patient was matched with up to 20 ‘unexposed’ patients 
with no record of self-harm in the CPRD at index episode date by gender, age (year of birth) and registered practice. We 
applied the same eligibility criteria for entry into both the self-harm cohort and the sampling frame for the matched 
comparison cohort.  
 
 
6 
 
Linked mortality data 
We obtained linked cause-specific mortality records and examined the underlying cause of death coded at the Office for 
National Statistics (ONS) using the International Classification of Disease 10th revision (ICD-10).
25
 The death registration 
records were available for patients registered with 385 practices, around 60% of all CPRD practices; i.e. those in England 
that participate in the CPRD scheme linking all patients with a valid National Health Service (NHS) identifier. We 
examined both natural and unnatural causes, with the latter defined as “… external causes, e.g. injury or poisoning, which 
includes death due to intentional injury, such as homicide or suicide, and death caused by unintentional injury in an 
accidental manner.”
26
 Unnatural deaths were classified according to all codes listed in ICD-10 Chapter XX ‘External 
Causes of Morbidity and Mortality’ (V01-Y98).
25
 As is accepted practice for UK-based epidemiological research, our 
suicide definition included 'open verdicts'.
27
 We examined natural causes because a significant proportion of people who 
harm themselves have a higher prevalence of lifestyle risk factors including smoking
28
 and excessive drinking
29
 that 
predict certain types of natural death, such as deaths from digestive diseases, respiratory diseases and lung cancer. To 
examine alcohol-related deaths, which are mostly from natural causes but also include acute alcohol poisonings, we used 
a standard ONS-endorsed coding range,
30,31
 and likewise for classification of drug poisoning deaths, which includes all 
fatal poisonings or overdoses with prescribed medication, medication purchased legally ‘over-the-counter’, or illicit 
drugs.
32
 The ICD-10 classifications for alcohol-related death and drug poisoning death are shown in Box 1 in Appendix 3.  
 
Area-level deprivation 
Based on patients’ residential postcodes, Index of Multiple Deprivation (IMD) quintiles were extracted from the CPRD.
33
 
The IMD measures area-level deprivation on the basis of several domains including income, employment, health, 
education, barriers to services (including housing), crime, and general living environment. It is derived for geographical 
areas designated as Lower-layer Super Output Areas (LSOA's)
34
 that contain 1000-3000 people and are Census-derived. 
The IMD provides a means of ranking and assessing whether an area is more or less deprived than others.   
 
Statistical analyses 
All analyses were performed using Stata software version 13.
35
 For all individuals in a matched set, we defined the study 
entry point as the date of the index self-harm episode. We conducted Cox regression survival analysis
36
 stratified by 
matched set. We generated both unadjusted hazard ratios and those adjusted for the following potential time-dependent 
confounders: calendar year, frequency of contact with a GP in past 12 months, mental illness diagnoses, psychotropic 
medication prescribed in past 12 months, clinically significant alcohol misuse, and current smoking status. The methods 
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used to generate these time-dependent covariates are described in Appendix 4. Right-censoring was applied at the end 
of the study period, and also to account for ‘migration’ from the database for reasons other than death, including 
geographical relocation or withdrawal of the patient’s practice from the CPRD, and death from other causes than the 
specific cause being examined.  
 
Results 
 
Descriptive analyses 
Table 1 presents socio-demographic indices for the 30,017 persons in the self-harm cohort versus the 600,258 individuals 
in the matched comparison cohort at index episode date. Because we matched patients on gender, age and registered 
practice, the proportional breakdown in the table was identical for both groups with respect to gender, age and practice-
level deprivation. Females, younger people and those registered at practices in deprived localities were overrepresented. 
Table 2 compares clinical characteristics at baseline, indicating that the self-harm and comparison cohorts differed 
markedly in terms of their patterns of clinical consultation, with the former tending to attend their practice much more 
frequently. The self-harm cohort had much higher prevalence of psychiatric history, referral to mental health services and 
psychotropic medication, and alcohol misuse, smoking and physical illness co-morbidity were also considerably more 
prevalent.  
 
Hazard ratios stratified by individual follow-up year 
A key consideration when fitting a Cox model is the proportional hazards assumption,
34
 which requires the hazard ratio to 
be consistent throughout follow-up. Figure 1 shows plots of hazard ratios and their 95% confidence intervals stratified by 
individual follow-up year. For all-cause mortality (Fig. 1a), suicide (Fig. 1b), natural death (Fig. 1c) and unnatural death 
(Fig. 1d), by far the greatest elevations in risk occurred during the first follow-up year. For natural death, the magnitude of 
the observed hazard ratio declined gradually in annual increments from first to the fourth follow-up year, whereas for 
suicide and for all unnatural deaths combined, risk was markedly higher for the first year than it was during the ensuing 9 
years of follow-up.  Because mortality risk was found to be elevated to a greater degree during the first follow-up year 
than for subsequent years in all four of these plots, we accounted for non-proportionality in risk
34
 over time for all the 
hazard ratios presented in Tables 3 and 4. Thus, for these tabulations we estimated two-stage hazard ratios separately 
for: (i) the first year of follow-up; (ii) follow-up thereafter. 
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Relative risk of dying within a year of the index self-harm episode vs. long-term follow-up 
Two-stage hazard ratio estimates for all-cause mortality, all natural causes and all unnatural causes are presented in 
Table 3. Two consistent patterns were found across these three broad mortality categories: 1) much greater risk during 
the first year versus subsequent follow-up years; 2) attenuated but still significant elevations in risk with covariate 
adjustment. Although a greater number of natural deaths were observed, the hazard ratios for unnatural death were 
considerably larger. Smaller effect sizes were observed for natural death, although, even with this outcome, an 
independent statistically significant elevation in risk persisted following adjustment. In Table 4 we present hazard ratios 
for the following specific causes of death: suicide, accident, alcohol-related, drug poisoning, respiratory disease and lung 
cancer. Self-harm was a strong and significant predictor for each of these outcomes, and the greatest risk elevations 
were for suicide. The increase in risk was more pronounced in the first year versus subsequent follow-up years, especially 
so for suicide. We did not observe any notable gender differences in the observed hazard ratios: likelihood ratio tests on 
gender interactions were not statistically significant for all causes of death (P=0.09), all natural causes (P=0.55), all 
unnatural causes (P=0.18), or suicide (P=0.14). 
 
Cumulative incidence of premature death at 1, 5 and 10 years after index self-harm episode 
Absolute risks are shown in Table 5. The numbers of deaths are summarized at varying lengths of follow-up for the self-
harm and comparison cohorts along with cumulative incidence values (presented as percentages). At 10 years of follow 
up, the cumulative incidence values in this predominantly younger aged cohort of people who had harmed themselves 
were 6.5% (CI 6.0-7.1) for all-cause mortality and 1.3% (CI 1.2-1.5) for suicide. 
 
Discussion 
 
Summary of findings 
Compared with a matched cohort of unaffected individuals, the self-harm cohort had markedly elevated risk of unnatural 
death during the first follow-up year. Beyond the first year, risk remained raised versus the comparison cohort, but to a 
considerably lesser degree. The largest elevation in risk within a year of the index self-harm episode and over longer term 
follow-up was for suicide. Risk of dying prematurely from a natural cause was elevated for both follow-up periods, albeit to 
a much lower degree than for dying by unnatural causes. Risks were raised across a broad array of cause-specific 
premature mortality outcomes, including suicide, accident, alcohol-related, drug poisoning, respiratory disease and lung 
cancer.         
9 
 
Comparison with existing evidence 
For the first time we report short- and long-term mortality risk in UK primary care patients whose episodes of self-harming 
behavior may or may not be known to hospital services. Our findings also confirm those from earlier investigations that 
have reported elevated risk of unnatural and natural mortality following self-harm.
3-11,37-41
 However, it is important to 
highlight that almost all previously published studies ascertained index self-harm episodes via secondary care data 
sources, mostly through emergency department contacts, although a small number of study cohorts were sampled from 
specialized poisoning treatment centers.
37
 Virtually all previous studies have reported relative risks for cause-specific 
mortality without stratifying these estimates by length of follow-up. For some smaller studies, these estimates may have 
been coalesced across the whole observation period to maximize statistical power. Our proportional hazards assumption 
testing
36
 revealed that such data pooling may yield invalid estimates averaged across the whole follow-up time, if the 
degree of risk elevation is substantially greater during the first follow-up year. Few investigations have reported relative 
risk restricted to the first follow-up year; two Taiwanese studies found age and gender adjusted risk elevations by a 100-
fold or more, one conducted in Nantou County
41
 and the other in Taipei City.
11
 The Multi-centre Study of Self-harm in 
England, conducted in the cities of Derby, Manchester and Oxford, reported on the shared characteristics and similarity of 
risk factors for suicide and accidental death following self-harm.
42
 It is therefore noteworthy that, in our study, risk of 
accidental death was also greatly elevated in the self-harm cohort.  
 
Strengths and limitations  
Our study had several major strengths. For the first time, we examined risks of all-cause and cause-specific premature 
death in a nationally representative primary care cohort, with complete case ascertainment via linkage to national 
mortality records. We used an optimal study design by comparing risks directly at individual patient level between an 
incident self-harm cohort and an unaffected comparison cohort sampled from the same population. This is a more robust 
approach than comparing risk indirectly via age and gender standardised mortality ratios calculated using nationally 
aggregated data, as was reported in previous studies.
5
 By delineating an incident cohort design we precluded prevalent-
cohort bias,
23,24 
which underestimates the strength of exposure-outcome associations, and which could have influenced 
previous investigations of this topic.
3-11
 Finally, our design was further enhanced by having up to 20 matched comparison 
subjects for every person in the self-harm cohort to enable examination of mortality outcomes that are particularly rare in 
the general population, such as suicide. 
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The study also had some limitations. First, we lacked the ability to examine confounding or effect modification by ethnicity
 
and individual-level socioeconomic status (beyond a score allocated at the patient-postcode level). Second, the mortality 
record linkage scheme implemented for most CPRD practices in England did not yet exist for CPRD practices in 
Scotland, Wales or Northern Ireland when the study was conducted. Thus, our findings may not be generalizable to the 
entire UK population.  
 
Interpretation and implications 
These findings should dispel any notion that a primary care patient cohort with recorded history of self-harm would have 
an appreciably lower risk of dying prematurely by suicide and other unnatural and natural causes of death than individuals 
ascertained via hospital emergency department contacts. This indicates that secondary care study cohorts, which are the 
prevailing setting for research conducted in the field, do not capture a population of higher-risk individuals compared with 
all registered primary care patients who have harmed themselves. From this information we can infer a strong and 
clinically important message for primary healthcare teams: that these patients have greatly elevated risk of suicide and 
other causes of premature death, especially within a year of a known self-harm episode. National guidelines could 
provide more specific recommendations and training on how primary healthcare teams can intervene, manage and 
monitor risk in these patients more effectively.
43
 Some of the risk factors identified, particularly alcohol misuse and 
smoking, are potentially modifiable. Furthermore, people who have harmed themselves consult much more frequently 
than their age and gender matched peers, which presents a clear opportunity for preventive action. Primary care patients 
with myriad co-morbidities, including self-harming behavior, mental disorder, addictions, and physical illnesses, will 
require a concerted, multi-pronged, multidisciplinary collaborative care model approach to enhance management of their 
complex health needs.
44
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Figure 1. Hazard ratios stratified by individual follow-up year 
 
(a) All-cause mortality (b) Suicide 
 
(c) Natural deaths (d) Unnatural deaths 
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Table 1. Socio-demographic characteristics at index self-harm episode 
   
Socio-demographics 
Self-harm cohort: 
N = 30,017 
Comparison cohort: 
N = 600,258 
n % n % 
     
Gender:     
 
Male 12,390 41.3 247,746 41.3 
Female 17,627 58.7 352,512 58.7 
Age in years:     
 
15-24 11,876 39.6 237,470 39.6 
25-34 6,028 20.1 120,541 20.1 
35-44 6,132 20.4 122,665 20.4 
45-54 3,995 13.3 79,869 13.3 
55-64 1,986 6.6 39,696 6.6 
Index of Multiple Deprivation:     
 
Quintile 1 (least deprived) 3,359 11.2 67,174 11.2 
Quintile 2 6,023 20.1 120,452 20.1 
Quintile 3 5,571 18.6 111,412 18.6 
Quintile 4 7,305 24.3 146,079 24.3 
Quintile 5 (most deprived) 7,759 25.9 155,141 25.9 
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Table 2. Clinical characteristics at index self-harm episode 
   
Clinical characteristics Self-harm cohort: 
N = 30,017 
Comparison cohort 
N = 600,258 
n % n % 
     
GP consultation in past 12 months:     
 0 visits 2,395 8.0 152,795 25.5 
1 or 2 visits 5,217 17.4 168,467 28.1 
3 to 5 visits 6,935 23.1 143,100 23.8 
6+ visits 15,470 51.5 135,896 22.6 
Mental health history:     
 Psychiatric diagnosis 16,513 55.0 126,301 21.0 
Referral to mental health services 8,506 28.3 39,653 6.6 
Psychotropic drug prescribed 20,377 67.9 191,874 32.0 
Alcohol misuse 2,069 6.9 4,352 0.7 
Physical health history: 
 Asthma 5,860 19.5 91,830 15.3 
Cancer 308 1.0 4,854 0.8 
CHD 348 1.2 3,729 0.6 
 CKD 114 0.4 1,400 0.2 
 COPD 193 0.6 1,453 0.2 
 Diabetes 849 2.8 8,896 1.5 
 Hypertension 1,455 4.8 23,653 3.9 
 Stroke 202 0.7 1,400 0.2 
Smoking status:     
 Never smoked 9,545 36.7 286,547 58.9 
Current smoker 13,507 52.0 134,538 27.7 
Ex-smoker 2,936 11.3 65,306 13.4 
 Unknown 4,029 - 113,867 - 
CHD: coronary heart disease; CKD: chronic kidney disease; COPD: chronic  
obstructive pulmonary disorder 
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Table 3. Unadjusted and adjusted two-stage hazard ratios for all-cause mortality, all natural deaths and all unnatural death 
    
Mortality type Follow-up period Self-harm cohort: Hazard ratio [95% CI] 
  Deaths (n) Rate per 1000 PYs Unadjusted Adjusted ¥ 
      
All-cause mortality Within a year 301 11.1 9.92 [8.63, 11.40] 3.59 [3.08, 4.19] 
 After a year 673 6.3 3.92 [3.61, 4.27] 1.70 [1.54, 1.88] 
      
All natural deaths Within a year 126 4.6 4.79 [3.94, 5.82] 1.51 [1.11, 1.87] 
 After a year 459 4.3 2.98 [2.69, 3.29] 1.25 [1.11, 1.40] 
      
All unnatural deaths Within a year 175 6.4 43.31 [33.20, 56.49] 21.11 [15.83, 28.15] 
 After a year 214 2.0 12.53 [10.48, 14.99] 5.65 [4.60, 6.94] 
 
PY = Person Year; CI = Confidence Interval. 
 
¥ Adjusted for consultation frequency in previous 12 months, history of psychiatric diagnoses, history of mental health referral, history of psychotropic medication prescribing, 
history of alcohol misuse, and smoking status. 
 
All natural versus unnatural deaths delineated using the following ICD-10 codes: Unnatural death: V01-Y98; Natural death: any code other than V01-Y98    
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Table 4. Unadjusted and adjusted two-stage hazard ratios for specific causes of death 
    
Cause of death Follow-up period Self-harm cohort: Hazard ratio [95% CI] 
  Deaths (n) Rate per 1000 PYs Unadjusted Adjusted ¥ 
      
Suicide Within a year 140 5.1 113.90 [73.87,175.63] 54.43 [34.32,86.32] 
 After a year 122 1.1 17.45 [13.50,22.54] 7.62 [5.67,10.25] 
      
Accident Within a year 35 1.3 12.94 [8.45,19.84] 5.60 [3.45,9.08] 
 After a year 90 0.8 9.32 [7.19,12.08] 4.16 [3.05,5.65] 
      
Alcohol-related Within a year 26 1.0 14.52 [8.74, 24.11] 2.62 [1.14, 6.02] 
 After a year 106 1.0 11.16 [8.72, 14.29] 2.37 [1.50, 3.76] 
      
Drug poisoning Within a year 49 1.8 48.17 [28.63, 81.03] 17.62 [9.83, 31.58] 
 After a year 91 0.8 28.46 [20.25, 39.98] 9.22 [6.14, 13.83] 
      
Respiratory disease Within a year 11 0.4 6.39 [3.24, 12.61] 2.64 [1.22, 5.70] 
 After a year 53 0.5 4.94 [3.63, 6.72] 2.21 [1.55, 3.15] 
      
Lung cancer Within a year 9 0.3 4.55 [2.20, 9.39] 2.31 [1.00, 5.30] 
 After a year 29 0.3 1.92 [1.31, 2.82] 0.88 [0.56, 1.37] 
 
PY = Person Year; CI = Confidence Interval 
 
¥ Adjusted for consultation frequency in previous 12 months, history of psychiatric diagnoses, history of mental health referral, history of psychotropic medication prescribing, 
history of alcohol misuse, and smoking status 
 
Causes of death delineated using the following ICD-10 codes: Suicide: X60-X84, Y10-Y34 (excluding Y33.9), Y87.0, Y87.2; Accident: V01-X59, Y85-Y86, Y87.1; Alcohol-
related: F10, G31.1, I42.6, K29.2, K70, K73, K74 (excluding K74.3-K74.5), K86.0, X45, X65, Y15; Drug poisoning: F11-F16, F18-F19, X40-X44, X60-X64, X85, Y10-Y14; 
Respiratory disease: J00-J99; Lung cancer: C33-C34. 
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Table 5. Cumulative incidence for all causes and specific causes of death 
 
Self-harm cohort: 
N = 30,017 
Comparison cohort: 
N = 600,258 
 
Number  
of deaths 
Cumulative 
incidence (%) 
Number  
of deaths 
Cumulative 
incidence (%) 
     
All causes:     
 At 1 year 301 1.07 (0.96, 1.20) 634 0.11 (0.10, 0.12) 
 At 5 years 739 3.47 (3.22, 3.73) 2777 0.68 (0.66, 0.71) 
 At 10 years 946 6.53 (6.04, 7.06) 4455 1.79 (1.73, 1.85) 
All natural causes:     
 At 1 year 126 0.46 (0.38, 0.54) 551 0.10 (0.09, 0.11) 
 At 5 years 406 2.01 (1.82, 2.22) 2435 0.60 (0.58, 0.63) 
 At 10 years 563 4.43 (4.00, 4.90) 3989 1.63 (1.57, 1.69) 
All unnatural causes:     
 At 1 year 175 0.62 (0.53, 0.72) 83 0.01 (0.01, 0.02) 
 At 5 years 333 1.49 (1.33, 1.66) 342 0.08 (0.07, 0.09) 
 At 10 years 383 2.21 (1.95, 2.49) 466 0.16 (0.15, 0.18) 
Suicide:     
 At 1 year 140 0.50 (0.42, 0.58) 27 0.00 (0.00, 0.01) 
 At 5 years 234 1.00 (0.88, 1.14) 131 0.03 (0.03, 0.04) 
 At 10 years 258 1.33 (1.15, 1.53) 182 0.07 (0.06, 0.08) 
Accidental:     
 At 1 year 35 0.12 (0.09, 0.17) 54 0.01 (0.01, 0.01) 
 At 5 years 97 0.48 (0.39, 0.59) 201 0.05 (0.04, 0.05) 
 At 10 years 123 0.88 (0.70, 1.09) 273 0.09 (0.08, 0.11) 
Alcohol-related:     
 At 1 year 26 0.09 (0.06, 0.14) 40 0.01 (0.01, 0.01) 
 At 5 years 94 0.48 (0.39, 0.59) 165 0.04 (0.03, 0.05) 
 At 10 years 132 1.03 (0.84, 1.27) 260 0.10 (0.09, 0.12) 
Drug poisoning:     
 At 1 year 49 0.17 (0.13, 0.23) 20 0.00 (0.00, 0.01) 
 At 5 years 116 0.54 (0.45, 0.65) 73 0.02 (0.01, 0.02) 
 At 10 years 138 0.86 (0.70, 1.06) 90 0.03 (0.02, 0.03) 
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Appendix 1: Explanation of the Read coding system and how diagnostic 
information is routinely recorded in the CPRD 
 
The Read classification was devised in the 1980s by English general practitioner (GP) James Read as 
a thesaurus of medical terms according to the following principles: 1) Comprehensive; 2) Hierarchical; 
3) Coded; 4) Computerized; 5) Cross-referenced; 6) Dynamic. It contains a vast array of codes for the 
following entities: disease diagnosis, management and monitoring; history, signs and symptoms; 
investigative, preventive, operative and therapeutic procedures; medication and appliances; and 
referrals to secondary care health services. By 1990 it was claimed to be “… the most comprehensive 
medical coding system in the world (p1092).”
18
 Read codes that denote a self-harm episode or a co-
morbid physical or mental health condition are routinely entered in a patient’s electronic medical 
record by their GP or practice nurse in the course of a clinical consultation, or by a practice 
administrator who has gleaned the information from a secondary healthcare provider. Thus, in some 
instances the patient’s GP or practice nurse will have made the diagnosis whilst in others it will have 
been made by a clinician who had previously seen the patient in a general hospital or a mental health 
unit. With self-harm episodes, some patients will have self-reported the behavior at consultation (e.g. 
“I intentionally cut my arm today”) or it will be recorded on the basis that the patient had self-poisoned 
or self-injured to a degree that consequently required clinical observation or treatment. 
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Appendix 2: Explanation of psychiatric and co-morbid physical illness 
diagnostic classifications 
 
Our schizophrenia-spectrum definition included diagnoses of delusional disorders, brief psychotic 
disorders, schizophreniform disorders, schizoaffective disorders, and schizophrenia. The spectrum 
definition also included patients with psychotic symptoms that did not adequately fit the definition for 
any of the specified diagnostic subgroups. We identified patients with bipolar disorder via records that 
referred directly to bipolar or affective disorder and records describing recurrent mania, manic-
depression, or depression with psychosis. We applied broad definitions for the two most common 
conditions: depression and anxiety. Our definition of depression included the full range of diagnoses 
from either single or recurrent episodes of mild to severe depression through to more persistent 
chronic conditions. Anxiety incorporated panic disorders, phobias, post-traumatic stress disorders, 
social anxiety disorders, and generalized anxiety disorder.  
 
Defining personality disorders can be complex due to the substantial overlap with other diagnostic 
categories. This is particularly true when considering variants that include some form of paranoia or 
psychosis. For instance, some definitions place schizoid and schizotypal personality disorders in the 
schizophrenia spectrum whereas our definition included these conditions as personality disorders 
when references to delusions or hallucinations were not present in the patient’s records. Our definition 
also incorporated erratic variants (including antisocial, borderline, histrionic, and narcissistic 
personality disorders) and anxiety or stress-related variants (including avoidant, dependent, and 
obsessive-compulsive personality disorders). The classification of eating disorders is also prone to 
subjectivity. Again, we applied a broad definition that covered the more common conditions (including 
anorexia nervosa, bulimia, and binge eating) but also included some rarer psychogenic variants. 
 
Table 2 (‘Clinical characteristics at index self-harm episode’) of the manuscript presents the 
prevalence of physical illness conditions that are monitored in the Quality Outcomes Framework 
(QOF), which has been part of the General Medical Services contract for general practices in the UK 
National Health Service since April 1
st
 2004: http://www.nhsemployers.org/your-workforce/primary-
care-contacts/general-medical-services/quality-and-outcomes-framework 
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Appendix 3: ICD-10 codes and descriptions for classifying alcohol-related 
death and drug poisoning death 
 
These two categories of cause-specific mortality are routinely reported by the Office for National 
Statistics (ONS), England and Wales: alcohol-related death;
30
 drug poisoning death.
32
 Box 1 presents 
the lists of codes used to classify these outcomes along with their respective descriptions. 
 
Box 1: ICD-10 classification for alcohol-related death and drug poisoning death 
  
ICD-10 code or range Description 
Alcohol-related death:  
F10 Mental and behavioral disorders due to use of alcohol 
G31.2 Degeneration of the nervous system due to alcohol 
G62.1 Alcoholic polyneuropathy 
I42.6 Alcohol gastritis 
K70 Alcoholic liver disease 
K73 Chronic hepatitis, not elsewhere classified 
K74 Fibrosis and cirrhosis of liver (excluding K74.3-K74.5 - Biliary cirrhosis) 
K86.0 Alcohol-induced chronic pancreatitis 
X45 Accidental poisoning by and exposure to alcohol 
X65 Intentional self-poisoning by and exposure to alcohol 
Y15 Poisoning by and exposure to alcohol - undetermined intent 
Drug poisoning death:  
F11-F16, F18-F19 Mental and behavioral disorders due to drug use  
X40-X44 Accidental self-poisoning by drugs, medicaments and biological substances 
X60-X64 Intentional self-poisoning by drugs, medicaments and biological substances 
X85 Assault by drugs, medicaments and biological substances 
Y10-Y14 Poisoning by drugs, medicaments and biological substances - undetermined intent 
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Appendix 4: Generating time-dependent covariates for multivariable modelling 
 
We fitted time-dependent covariates to account for potential confounders of the relationship between 
self-harm and premature mortality risk. With cohort entry as the origin for a given patient, we derived 
covariates at time points t = t1, t2, t3,… where t > 0.  
(a) Calendar year. To account for any trends in the relationship between self-harm and premature 
mortality, we adjusted for the calendar year at each time point t.  
(b) Frequency of contact with a GP in past 12 months. We applied a previously developed consultation 
categorization scheme to identify face-to-face patient contacts with clinical staff.
45
 When a patient had 
more than one consulting record on the same day, we regarded it as a single consultation, or 'contact 
day'. At each time point t (for each patient), we identified all direct contacts in the interval [t –12 
months, t ). 
(c) Mental illness diagnoses. We considered diagnoses of mental illness in the following six 
categories: the schizophrenia-spectrum, bipolar disorders, depression, anxiety disorders, personality 
disorders, and eating disorders. Appendix 2 contains detailed information on diagnostic category 
specifications; read code lists are available at: https://clinicalcodes.rss.mhs.man.ac.uk/. We 
constructed a binary time-dependent variable for a history of mental illness diagnoses on or prior to 
each time point t.  
(d) Referral to mental health services. We identified relevant referrals to specialist mental health 
services using the family health services authority (FHSA) specialty which indicated the department to 
which the patient was referred; it is mandatory for GPs to enter this information upon referral. For our 
purposes, there was just one relevant specialty: psychiatry. Secondly, information on the National 
Health Service (NHS) specialty was also available. The information in this field was more granular, but 
completion by general practice staff is not compulsory when coding referrals. We combined the 
information from both fields to construct indicators for each patient’s referral history. 
(e) Psychotropic medication prescribed in past 12 months. The dataset also contained records of 
primary care prescribed medication for our study cohort. GPs selected and recorded prescription items 
using the Multilex product dictionary. Information on the Multilex coding system is available at: 
http://www.fdbhealth.co.uk/solutions/multilex/. Dictionary items include medicinal products, devices 
and appliances. We extracted all prescriptions for our cohort in the following classes of psychotropic 
medication: typical, atypical and depot  antipsychotics; lithium and other mood stabilisers; selective 
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serotonin reuptake inhibitor (SSRI), tricyclic and other antidepressants; benzodiazepines; opioid 
analgesics; other anxiolytics and hypnotics. Our categorized lists of Multilex codes for psychotropic 
medication are also available at www.clinicalcodes.org. We constructed a binary indicator variable for 
any psychotropic prescription in the interval [t –12 months, t ). 
(f) Clinically significant alcohol misuse. We constructed binary indicator variables representing any 
history of clinically significant alcohol misuse prior to time t. The read code list is provided at: 
 https://clinicalcodes.rss.mhs.man.ac.uk/ 
(g) Current smoking status. Defining this covariate at each time point required a complex algorithm to 
address coding inconsistencies over time. We created a categorical variable for never smoked, current 
smoker and ex-smoker. The list of read codes for current smoking status is available at: 
https://clinicalcodes.rss.mhs.man.ac.uk/ Feasible one-step changes in smoking status over time were 
specified using the state transition matrix that is outlined here: 
   Status at time tj: 
   Never Current Ex 
Status 
at time 
tj-1: 
Never 1 1 1 
Current 0 1 1 
Ex 0 1 1 
 
 
